Dr Sholeh Feizi
Postdoctoral Researcher
Adelaide Medical School
Faculty of Health and Medical Sciences
Sholeh Feizi completed her PhD with the ENT Surgery group in 2022. Her research is focused on cellular biology and microbiology techniques; designing and conducting experiments; animal work; clinical trials, etc.
-
Appointments
Date Position Institution name 2021 - ongoing Postdoctoral Researcher University of Adelaide 2018 - 2021 Higher Degree by Research Candidate University of Adelaide -
Language Competencies
Language Competency English Can read, write, speak, understand spoken and peer review Persian Can read, write, speak, understand spoken and peer review -
Education
Date Institution name Country Title 2018 - 2021 University of Adelaide Australia PhD -
Research Interests
-
Journals
Year Citation 2024 Murphy, W., Liu, S., Javadiyan, S., Vyskocil, E., Feizi, S., Callejas, C., . . . Psaltis, A. J. (2024). An In Vitro Study Evaluating the Safety of Mesalazine on Human Nasoepithelial Cells. International Journal of Molecular Sciences, 25(5), 12 pages.
2024 Murphy, W., Liu, S., Hon, K., Finnie, J., Bouras, G. S., Feizi, S., . . . Psaltis, A. J. (2024). A Novel Model of Staphylococcus aureus-Induced Lymphoplasmacytic Rhinosinusitis in Rats. International Journal of Molecular Sciences, 25(6), 13 pages.
2024 Shaghayegh, G., Cooksley, C., Bouras, G., Panchatcharam, B. S., Feizi, S., Javadian, S., . . . Vreugde, S. (2024). S. aureus biofilm properties correlate with immune B cell subset frequencies and severity of chronic rhinosinusitis. Clinical Immunology, 263, 110221.
2023 Feizi, S., Cooksley, C. M., Ramezanpour, M., Nepal, R., Psaltis, A. J., Wormald, P. J., & Vreugde, S. (2023). Colloidal silver against macrophage infections and biofilms of atypical mycobacteria. BioMetals, 36(4), 913-925.
Scopus2 WoS1 Europe PMC12023 Nepal, R., Houtak, G., Bouras, G., Ramezanpour, M., Feizi, S., Shaghayegh, G., . . . Vreugde, S. (2023). Prophage acquisition by<i>Staphylococcus aureus</i>contributes to the expansion of Staphylococcal immune evasion.
2023 Feizi, S., Awad, M., Nepal, R., Cooksley, C. M., Psaltis, A. J., Wormald, P. J., & Vreugde, S. (2023). Deferiprone-gallium-protoporphyrin (IX): A promising treatment modality against Mycobacterium abscessus. Tuberculosis, 142, 7 pages.
2022 Feizi, S., Cooksley, C. M., Nepal, R., Psaltis, A. J., Wormald, P. -J., & Vreugde, S. (2022). Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients. Pathology, 54(4), 453-459.
Scopus15 WoS6 Europe PMC92021 Feizi, S., Cooksley, C. M., Bouras, G. S., Prestidge, C. A., Coenye, T., Psaltis, A. J., . . . Vreugde, S. (2021). Colloidal silver combating pathogenic Pseudomonas aeruginosa and MRSA in chronic rhinosinusitis.. Colloids and surfaces. B, Biointerfaces, 202, 1-10.
Scopus14 WoS13 Europe PMC72021 Feizi, S., Javadiyan, S., Cooksley, C. M., Shaghayegh, G., Psaltis, A. J., Wormald, P., & Vreugde, S. (2021). Green synthesized colloidal silver is devoid of toxic effects on primary human nasal epithelial cells in vitro. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 157, 112606-1-112606-10.
Scopus6 WoS2 Europe PMC12018 Feizi, S., Taghipour, E., Ghadam, P., & Mohammadi, P. (2018). Antifungal, antibacterial, antibiofilm and colorimetric sensing of toxic metals activities of eco friendly, economical synthesized Ag/AgCl nanoparticles using Malva Sylvestris leaf extracts. Microbial Pathogenesis, 125, 33-42.
Scopus47 WoS35 Europe PMC142017 Abbasi, Z., Feizi, S., Taghipour, E., & Ghadam, P. (2017). Green synthesis of silver nanoparticles using aqueous extract of dried Juglans regia green husk and examination of its biological properties. Green Processing and Synthesis, 6(5), 477-485.
Scopus36 WoS21
Connect With Me
External Profiles
